LABEL MANAGEMENT SOFTWARE
Simplifies artwork updates and changes
Shortens artwork and packaging design and approval timelines
Minimizes artwork and labeling errors and more…
The pharmaceutical industry is responding to expiring drug patents and increasing competition from generics by focusing on the introduction of both new products and multiple variants of existing products, into many markets.
Labeling, packaging and artwork design and production have proven a challenging operational activity. Ever-changing regulatory statements, language translations and patient-led design considerations can all impact your timescales for producing high quality drug labels and packaging, and thereby introducing risk and cost for new products.
If you do not identify and resolve errors in product labeling and packaging, any resulting product recalls will not only have a financial implication, but also a significant impact on the reputation and trust the brand has with patients, prescribers, regulators and other stakeholders.
Our label and artwork management solution, PRISYM 360, is designed to enable error-free, high quality packaging and labels to be produced efficiently; regardless of whether you’re a multi-national organization with several thousand products, or a small company with resource or expertise constraints.
Across the Life Sciences industry worldwide, the way in which organizations approach the design, creation and printing of labels...
CHOSEN BY THESE CUSTOMERS...
OFFERING THE PERFECT OPTION FOR YOU
Label and Artwork Management Solution for Medical Device, Clinical Trials and Pharmaceutical sectors.
We offer tiers of deployment to suit your needs and size of the business. But our offer is much more than just deployment.
We are the only software vendor in life science industry who supplies in- house validation documentation and implementation support.
PHARMACEUTICAL LABELING RESOURCES
Labeling Webinar Series - A Date with the Experts on Global Labeling Systems
Medical device and pharmaceutical organizations are constantly looking at ways to avoid labeling errors which are a major reason for FDA product recalls.